Regulation of the cell proliferation and migration as extra-pituitary functions of GnRH

General and Comparative Endocrinology

Volumn 181, Issue 1, 2013, Pages 259-264

  Park, Min Kyun ^a   Kanaho, Yoh Ichiro ^a   Enomoto, Masahiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Cell migration; Cell proliferation; Colony formation; Evolution; GnRH; Pituitary

Indexed keywords

GONADORELIN; GONADOTROPIN;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONCENTRATION RESPONSE; GONADOTROPIN RELEASE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS; IMMUNOMODULATION; MOLECULAR EVOLUTION; NEUROMODULATION; NONHUMAN; OVARY FOLLICLE ATRESIA; OVULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 84873057979     PISSN: 00166480     EISSN: 10956840     Source Type: Journal    
DOI: 10.1016/j.ygcen.2012.09.023     Document Type: Article

References (84)

1. Aguilar-Rojas A., Huerta-Reyes M. Human gonadotropin-releasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cells. Oncol. Rep. 2009, 22:981-990.
2. Aksel S. Luteinizing hormone-releasing hormone and the human menstrual cycle. Am. J. Obstet. Gynecol. 1979, 135:96-101.
3. Andreis P.G., Neri G., Nussdorfer G.G. Effect of luteinizing hormone-releasing hormone on rat adrenocortical cells. J. Steroid. Biochem. Mol. Biol. 1997, 63:17-19.
4. Ataya K.M., Sakr W., Blacker C.M., Mutchnick M.G., Latif Z.A. Effect of GnRH agonists on the thymus in female rats. Acta Endocrinol. (Copenh.) 1989, 121:833-840.
5. Azad N., LaPaglia N., Kirsteins L., Uddin S., Steiner J., Williams D.W., et al. Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone. J. Endocrinol. 1997, 153:241-249.
6. Batticane N., Morale M.C., Gallo F., Farinella Z., Marchetti B. Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. Endocrinology 1991, 129:277-286.
7. Belisle S., Guevin J.F., Bellabarba D., Lehoux J.G. Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin. J. Clin. Endocrinol. Metab. 1984, 59:119-126.
8. Billig H., Furuta I., Hsueh A.J. Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulose cells. Endocrinology 1994, 134:245-252.
9. Bourne G.A., Regiani S., Payne A.H., Marshall J.C. Testicular GnRH receptors - characterization and localization on interstitial tissue. J. Clin. Endocrinol. Metab. 1980, 51:407-409.
10. Chieffi G., Pierantoni R., Fasano S. Immunoreactive GnRH in hypothalamic and extrahypothalamic areas. Int. Rev. Cytol. 1991, 127:1-55.
11. Ching M. Correlative surges of LHRH, LH and FSH in pituitary stalk plasma and systemic plasma of rat during proestrus. Neuroendocrinology 1982, 34:279-285.
12. Clayton R.N., Harwood J.P., Catt K.J. Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production. Nature 1979, 282:90-92.
13. Clayton R.N., Katikineni M., Chan V., Dufau M.L., Catt K.J. Direct inhibition of testicular function by gonadotropin-releasing hormone: mediation by specific gonadotropin-releasing hormone receptors in interstitial cells. Proc. Natl. Acad. Sci. USA 1980, 77:4459-4463.
14. Daikoku-Ishido H., Okamura Y., Yanaihara N., Daikoku S. Development of the hypothalamic luteinizing hormone-releasing hormone-containing neuron system in the rat: in vivo and in transplantation studies. Dev. Biol. 1990, 140:374-387.
15. Dondi D., Moretti R.M., Marelli M.M., Pratesi G., Pollizi D., Milani M., et al. Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonisits on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice. Int. J. Cancer 1998, 76:506-511.
16. Eidne K.A., Flangan C.A., Harris N.S., Miller R.P. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists. J. Clin. Endocrinol. Metab. 1987, 64:425-432.
17. Eisthen H.L., Delay R.J., Wirsig-Wiechmann C.R., Dionne V.E. Neuromodulatory effects of gonadotropin releasing hormone on olfactory receptor neurons. J. Neurosci. 2000, 20:3947-3955.
18. Emons G., Ortmann O., Becker M., Irmer G., Springer B., Laun R., et al. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines. Cancer Res. 1993, 53:5439-5446.
19. Enomoto M., Endo D., Kawashima S., Park M.K. Human type II GnRH receptor mediates effects of GnRH on cell proliferation. Zool. Sci. 2004, 21:763-770.
20. Enomoto M., Mori T., Park M.K. GnRH agonist Buserelin affects colony-forming efficiency of HHUA and Jurkat cells. Biochem. Biophys. Res. Commun. 2001, 289:1180-1187.
21. Enomoto M., Park M.K. Influence of serum supplements in culture medium on gonadotropin-releasing hormone effects on colony formation. Life Sci. 2002, 71:2153-2160.
22. Enomoto M., Park M.K. GnRH as a cell proliferation regulator: mechanism of action and evolutionary implications. Zool. Sci. 2004, 21:1005-1013.
23. Enomoto M., Seong J.Y., Kawashima S., Park M.K. Proliferation of TSU-Pr1, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone. Life Sci. 2004, 74:3141-3152.
24. Enomoto M., Utsumi M., Park M.K. Gonadotropin-releasing hormone induces actin cytoskeleton remodeling and affects cell migration in a cell-type-specific manner in TSU-Pr1 and DU145 cells. Endocrinology 2006, 147:530-542.
25. Faurholm B., Millar R.P., Katz A.A. The genes encoding the type II gonadotropin-releasing hormone receptor and the ribonucleoprotein RBM8A in humans overlap in two genomic loci. Genomics 2001, 78:15-18.
26. Fekete M., Redding T.W., Comaru-Shally A.M., Pontes J.E., Connelly R.W., Srkalovic G., et al. Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia. Prostate 1989, 14:191-208.
27. Franca C.M., Jaeger R.G., Freitas V.M., Araujo N.S., Jaeger M.M. Effect of N-CAM on in vitro invasion of human adenoid cystic carcinoma cells. Oral Oncol. 2001, 37:638-642.
28. Funabashi T., Daikoku S., Shinohara K., Kimura F. Pulsatile gonadotropin-releasing hormone (GnRH) secretion is an inherent function of GnRH neurons, as revealed by the culture of medial olfactory placode obtained from embryonic rats. Neuroendocrinology 2000, 71:138-144.
29. Gillis S., Watson J. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 1980, 152:1709-1719.
30. Gonzales-Barcena D., Ibarra-Olmons M.A., Garcia-Carrasco F., Gutierrez-Samperio C., Comaru-Shally A.M., Shally A.V. Influence of D-Trp6-LH-RH on the survival time in patients with advanced pancreatic cancer. Biomed. Pharmacother. 1989, 43:313-317.
31. Grundker C., Gunthert A.R., Westphalen S., Emons G. Biology of the gonadotropin-releasing hormone system in gynecological cancers. Eur. J. Endocrinol. 2002, 146:1-14.
32. Iizumi T., Yazaki T., Kanoh S., Kondo I., Koiso K. Establishment of a new prostatic carcinoma cell line (TSU-Pr1). J. Urol. 1987, 137:1304-1306.
33. Imai A., Takagi A., Horibe S., Takagi H., Tamaya T. Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated Fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death. J. Clin. Endocrinol. Metab. 1998, 83:427-431.
34. Ishiwata I., Ishiwata C., Soma M., Arai J., Ishikawa H. Establishment of human endometrial adenocarcinoma cell line containing estradiol-17 beta and progesterone receptors. Gynecol. Oncol. 1984, 17:281-290.
35. Iwashita M., Evans M.I., Catt K.J. Characterization of a gonadotropin-releasing hormone receptor site in term placenta and chorionic villi. J. Clin. Endocrinol. Metab. 1986, 62:127-133.
36. Kah O., Lethimonier C., Somoza G., Guilgur L.G., Vaillant C., Lareyre J.J. GnRH and GnRH receptors in metazoan: a historical, comparative, and evolutive perspective. Gen. Comp. Endocrinol. 2007, 153:346-364.
37. Kakar S.S., Nath S., Bunn J., Jennes L. The inhibition of growth and down-regulation of gonadotropin releasing hormone (GnRH) receptor in alphaT3-1 cells by GnRH agonist. Anticancer Drugs 1997, 8:369-375.
38. Kanaho Y.-I., Enomoto M., Endo D., Maehiro S., Park M.K., Murakami S. Neurotrophic effect of GnRH on neurite extension and neuronal migration of embryonic GnRH neurons in chick olfactory nerve bundle culture. J. Neurosci. Res. 2009, 87:2237-2244.
39. Kleinman D., Douvdevani A., Schally A.V., Levy J., Sharoni Y. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis. Am. J. Obstet. Gynecol. 1994, 170:96-102.
40. Kleinman H.K., Martin G.R. Matrigel, basement membrane matrix with biological activity. Semin. Cancer Biol. 2005, 15:378-386.
41. Knecht M., Ranta T., Feng P., Shinohara O., Catt K.J. Gonadotropin-releasing hormone as a modulator of ovarian function. J. Steroid. Biochem. 1985, 23:771-778.
42. Kogo H., Fujimoto T., Park M.K., Mori T. Gonadotropin-releasing hormone receptor mRNA expression in the ovaries of neonatal and adults rats. Cells Tissues Organs 1999, 164:14-22.
43. Kogo H., Kudo A., Park M.K., Mori T., Kawashima S. In situ detection of gonadotropin-releasing hormone (GnRH) receptor mRNA expression in the rat ovarian follicles. J. Exp. Zool. 1995, 272:62-68.
44. Leeb S.N., Vogl D., Falk W., Scholmerich J., Rogler G., Gelbmann C.M. Regulation of migration of human colonic myofibroblasts. Growth Factors 2002, 20:81-91.
45. Maier C.C., Marchetti B., LeBoeuf R.D., Blalock J.E. Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA. Cell. Mol. Neurobiol. 1992, 12:447-454.
46. Marchetti B., Guarcello V., Morale M.C., Bartoloni G., Farinella Z., Cordaro S., et al. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function. Endocrinology 1989, 125:1025-1036.
47. Marchetti B., Guarcello V., Morale M.C., Bartoloni G., Palumbo G., Raiti F., Cutuli N., Farinella Z., Scapagnini U. A physiological role for the neuropeptide luteinizing hormone-releasing hormone (LHRH) during the maturation of thymus gland function. Int. J. Neurosci. 1990, 51:287-289.
48. Marchetti B., Guarcello V., Morale M.C., Bartoloni G., Raiti F., Palumbo G., Farinella Z., Cordaro S., Scapagnini U. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology 1989, 125:1037-1045.
49. Martinez-Fuentes A.J., Hu L., Krsmanovic L.Z., Catt K.J. Gonadotropin-releasing hormone (GnRH) receptor expression and membrane signaling in early embryonic GnRH neurons: role in pulsatile neurosecretion. Mol. Endocrinol. 2004, 18:1808-1817.
50. Mickey D.D., Stone K.R., Wunderli H., Mickey G.H., Vollmer R.T., Paulson D.F. Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res. 1977, 37:4049-4058.
51. Miles L.E., Hanyaloglu A.C., Dromey J.R., Pfleger K.D., Eidne K.A. Gonadotropin-releasing hormone receptor-mediated growth suppression of immortalized LbetaT2 gonadotrope and stable HEK293 cell lines. Endocrinology 2004, 145:194-204.
52. Millar R., Lowe S., Conklin D., Pawson A., Maudsley S., Troskie B., et al. A novel mammalian receptor for the evolutionarily conserved type II GnRH. Proc. Natl. Acad. Sci. USA 2001, 98:9636-9641.
53. Miller W.R., Scott W.N., Morris R., Fraser H.M., Sharpe R.M. Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature 1985, 313:231-233.
54. Morgan K., Conklin D., Pawson A.J., Sellar R., Ott T.R., Millar R.P. A transcriptionally active human type II gonadotropin-releasing hormone receptor gene homolog overlaps two genes in the antisense orientation on chromosome 1q.12. Endocrinology 2003, 144:423-436.
55. Mulrenin E.M., Witkin J.W., Silverman A.J. Embryonic development of the gonadotropin-releasing hormone (GnRH) system in the chick: a spatio-temporal analysis of GnRH neuronal generation, site of origin, and migration. Endocrinology 1999, 140:422-433.
56. Murakami S., Seki T., Wakabayashi K., Arai Y. The ontogeny of luteinizing hormone-releasing hormone (LHRH) producing neurons in the chick embryo: possible evidence for migrating LHRH neurons from the olfactory epithelium expressing a highly polysialylated neural cell adhesion molecule. Neurosci. Res. 1991, 12:421-431.
57. Nagata I., Ono K., Kawana A., Kimura-Kuroda J. Aligned neurite bundles of granule cells regulate orientation of Purkinje cell dendrites by perpendicular contact guidance in two-dimensional and three-dimensional mouse cerebellar cultures. J. Comp. Neurol. 2006, 499:274-289.
58. Nam S.W., Clair T., Schiffmann E., Liotta L.A., Stracke M.L. A sensitive screening assay for secreted motility-stimulating factors. Cell Motil. Cytoskeleton 2000, 46:279-284.
59. Neill J.D., Duck L.W., Sellers J.C., Musgrove L.C. A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates. Biochem. Biophys. Res. Commun. 2001, 282. 1012-1008.
60. Norgren R.B., Lehman M.N. Neurons that migrate from the olfactory epithelium in the chick express luteinizing hormone-releasing hormone. Endocrinology 1991, 128:1676-1678.
61. Oka Y. Physiology and release activity of GnRH neurons. Prog. Brain Res. 2002, 141:259-281.
62. Pati D., Habibi H.R. Inhibition of human hepatocarcinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones. Endocrinology 1995, 136:75-84.
63. Radulovic S., Comaru-Schally A.M., Milovanovic S., Schally A.V. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice. Pancreas 1993, 8:88-97.
64. Redding T.W., Schally A.V. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. USA 1983, 80:1459-1462.
65. Redding T.W., Schally A.V., Tice T.R., Meyers W.E. Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp-6]luteinizing hormone-releasing hormone from injectable microcapsules. Proc. Natl. Acad. Sci. USA 1984, 81:5845-5848.
66. Roch G.J., Busby E.R., Sherwood N.M. Evolution of GnRH: diving deeper. Gen. Comp. Endocrinol. 2011, 171:1-16.
67. RosaeSilva A.A., Lamano-Carvalho T.L., Queiroz A.N. Effect of LH-RH analog on cat testis and adrenal cortex function. Braz. J. Med. Biol. Res. 1991, 24:1107-1111.
68. Sakai T., Inoue K., Hasegawa Y., Kurosumi K. Effect of passive immunization to gonadotropin-releasing hormone (GnRH) using GnRH antiserum on the mitotic activity of gonadotrophs in castrated male rats. Endocrinology 1988, 122:2803-2808.
69. Sarda A.K., Barnes M.A., Nair R.M. Inter-relationship between changing patterns of LHRH and gonadotropins in the menstrual cycle. Clin. Endocrinol. (Oxf.) 1981, 15:265-273.
70. Sarkar D.K., Chiappa S.A., Fink G., Sherwood N.M. Gonadotropin-releasing hormone surge in pro-oestrous rats. Nature 1976, 264:461-463.
71. Schally A.V. Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis. Peptides 1999, 20:1247-1262.
72. Schwanzel-Fukuda M., Pfaff D.W. Origin of luteinizing hormone-releasing hormone neurons. Nature 1989, 338:161-164.
73. Sharoni Y., Bosin E., Miinster A., Levy J., Schally A.V. Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone. Proc. Natl. Acad. Sci. USA 1989, 86:1648-1651.
74. Shirasaki R., Tamada A., Katsumata R., Murakami F. Guidance of cerebellofugal axons in the rat embryo: directed growth toward the floor plate and subsequent elongation along the longitudinal axis. Neuron 1995, 14:961-972.
75. Sifer C., Blanc-Layrac G., Bringuier A.F., Porcher R., Madelenat P., Feldmann G., et al. Effects of a gonadotropin-releasing hormone agonist and follicle stimulating hormone on the incidence of apoptosis in human luteinized granulosa cells. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003, 110:43-48.
76. Stone K.R., Mickey D.D., Wunderli H., Mickey G.H., Paulson D.F. Isolation of a human prostate carcinoma cell line (DU 145). Int. J. Cancer 1978, 21:274-281.
77. Szende B., Srkalovic G., Schally A.V., Lapis K., Groot K. Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression. Cancer 1990, 65:2279-2290.
78. Szende B., Zalatnai A., Schally A.V. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. Proc. Natl. Acad. Sci. USA 1989, 86:1643-1647.
79. Terasawa E., Keen K.L., Mogi K., Claude P. Pulsatile release of luteinizing hormone-releasing hormone (LHRH) in cultured LHRH neurons derived from the embryonic olfactory placode of the rhesus monkey. Endocrinology 1999, 140:1432-1441.
80. Tsai P.-S., Zhang L. The emergence and loss of Gonadotropin-releasing hormone in protostomes: orthology, phylogeny, structure, and function. Biol. Reprod. 2008, 79:798-805.
81. Waldmann H., Lefkovits I., Quintáns J. Limiting dilution analysis of helper T-cell function. Immunology 1975, 28:1135-1148.
82. Wray S., Grant P., Gainer H. Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc. Natl. Acad. Sci. USA 1989, 86:8132-8136.
83. Yates C., Wells A., Turner T. Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. Br. J. Cancer 2005, 92:366-375.
84. Zhao S., Saito H., Wang X., Saito T., Kaneko T., Hiroi M. Effects of gonadotropin-releasing hormone agonist on the incidence of apoptosis in porcine and human granulosa cells. Gynecol. Obstet. Invest. 2000, 49:52-56.